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Abstract
Background: A lot of studies have showed an excess maternal transmission of type 2 diabetes
(T2D). The aim, therefore, of the present study was to estimate the prevalence of familial history
of T2D in Greek patients, and to evaluate its potential effect on the patient's metabolic control and
the presence of diabetic complications.
Methods: A total of 1,473 T2D patients were recruited. Those with diabetic mothers, diabetic
fathers, diabetic relatives other than parents and no known diabetic relatives, were considered
separately.
Results: The prevalence of diabetes in the mother, the father and relatives other than parents, was
27.7, 11.0 and 10.7%, respectively. Patients with paternal diabetes had a higher prevalence of
hypertension (64.8 vs. 57.1%, P = 0.05) and lower LDL-cholesterol levels (115.12 ± 39.76 vs. 127.13
± 46.53 mg/dl, P = 0.006) than patients with diabetes in the mother. Patients with familial diabetes
were significantly younger (P < 0.001), with lower age at diabetes diagnosis (P < 0.001) than those
without diabetic relatives. Patients with a diabetic parent had higher body mass index (BMI) (31.22
± 5.87 vs. 30.67 ± 5.35 Kg/m2, P = 0.08), higher prevalence of dyslipidemia (49.8 vs. 44.6%, P = 0.06)
and retinopathy (17.9 vs. 14.5%, P = 0.08) compared with patients with no diabetic relatives. No
difference in the degree of metabolic control and the prevalence of chronic complications were
observed.
Conclusion: The present study showed an excess maternal transmission of T2D in a sample of
Greek diabetic patients. However, no different influence was found between maternal and paternal
diabetes on the clinical characteristics of diabetic patients except for LDL-cholesterol levels and
presence of hypertension. The presence of a family history of diabetes resulted to an early onset
of the disease to the offspring.
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Background
It is well established that the prevalence of type 2 diabetes
(T2D) is rising worldwide [1]. While environmental fac-
tors, such obesity and lack of physical activity, play an
important role to the rapid increase in the prevalence of
T2D, genetic factors are also important for the increased
risk of T2D [2]. Studies have estimated that risk for diag-
nosed T2D increases approximately two- to fourfold when
one or both parents are affected [3,4]. Moreover, the pres-
ence of a familial history of diabetes has been related with
high fasting plasma levels of glucose, lipids, [5], systolic
blood pressure [6], and body mass index (BMI) [7] in the
offsprings.
A lot of studies have showed an excess maternal transmis-
sion of T2D in different populations [3,8,9]. Genetic fac-
tors, such as mitochondrial DNA mutations [10], and
environmental mechanisms, such as intrauterine environ-
ment [11], have been proposed for the explanation of the
excess maternal transmission of T2D. However, studies in
populations with increased prevalence of T2D have not
confirmed the excess maternal transmission [12].
To the best of our knowledge the patterns of familial
transmission of T2D in our country have not been studied
so far. The aim, therefore, of the present study was to eval-
uate possible differences in the prevalence of maternal
and paternal history of T2D in Greek patients, and to eval-
uate their impact on the patient's metabolic control and
diabetic complications.
Methods
We examined a total of 1,473 subjects with type 2 diabetes
attending the diabetes outpatient clinic of our hospital
from January 2003 to December 2007. Diagnosis of dia-
betes was based on the American Diabetes Association cri-
teria [13]. Patients with at least three visits the last year
were enrolled in the study. A detailed medical history,
regarding the age at diagnosis of diabetes, the presence of
cardiovascular disease, the presence of diabetic complica-
tions, and current medication, was obtained.
Blood samples were drawn after 10–12 hours fast, for
measurement of plasma HbA1c and lipid profile. Body
weight with subjects in light clothing without shoes and
height was measured and body mass index (BMI) was cal-
culated. Blood pressure was recorded as the mean of three
consecutive measurements in the sitting position taken 5
min apart. Hypertension was defined according to the cur-
rent guidelines [14] as BP levels ≥ 140/90 mmHg or the
use of anti-hypertensive drugs.
Coronary artery disease (CAD) was defined as presence of
angina, history of previous myocardial infarction, positive
stress testing, revascularization procedures or stenosis >
50% at the coronary arteries. The renal status was based
on the albumin excretion rate (AER) measured in at least
two out of three consecutive 24-h timed urine collections.
Patients were classified as normo- (AER< 20 micrograms/
min), micro- (AER 20–199 micrograms/min), or mac-
roalbuminurics (AER > 200 micrograms/min). Direct fun-
doscopy was performed in all patients through dilated
pupils.
Each patient was asked whether any of his/her family
members (living or not) had diabetes, diagnosed by a
physician. Patients with a diabetic mother, a diabetic
father, diabetic relatives other than parents and no known
diabetic relatives, were considered separately. If there was
both a parent and relatives other than parents with diabe-
tes, only the parent was considered in subgrouping the
patient.
The study protocol was approved by the Scientific and
Ethical Committee of the General Hospital of Nikaia. Full
informed written consent was obtained from all patients.
Statistical analysis
Statistical analysis was preformed using programs availa-
ble in the SPSS statistical package (SPSS 10.0, Chicago,
USA). All variables were tested for normal distribution of
the data. Data are presented as means ± standard devia-
tion or percentages. Differences between the studied
groups examined using the student's unpaired t-test or the
Mann-Whitney U-test for parametric and non-parametric
data, respectively, while a chi-square test was used for cat-
egorical data. Bivariate correlations were performed using
the Pearson or the Spearman correlation coefficient, as
appropriate. P-values < 0.05 were considered statistically
significant.
Results
Of the total study population, 53.6% (789) reported a
family history of diabetes. The prevalence of diabetes in
the mother, the father and relatives other than parents,
was 27.7 (n = 408), 11.0 (n = 162) and 10.7% (n = 158),
respectively. 184 patients reported more than one diabetic
family member (12.5%). Only 60 patients had both par-
ents with known diabetes (4.1%) [this subgroup was used
in the comparison between subjects with parents with dia-
betes vs. subjects with no relatives with diabetes].
Subjects with diabetic mother vs. subjects with diabetic 
father
No significant difference was found in the clinical charac-
teristics of patients according to the presence of diabetes
in the mother or father, except for the significantly higher
LDL-cholesterol in patients with diabetes in the mother (P
= 0.006). On the contrary, diabetic subjects with diabetes
in the father had a higher prevalence of hypertension thanBMC Endocrine Disorders 2009, 9:12 http://www.biomedcentral.com/1472-6823/9/12
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diabetic subjects with diabetes in the mother (P = 0.05)
(Table 1).
There were no significant differences regarding age, gen-
der distribution, BMI, age at diabetes diagnosis, blood
pressure, HbA1c, plasma total cholesterol levels, HDL-cho-
lesterol levels, triglycerides levels, prevalence of dyslipi-
demia, retinopathy, nephropathy, CAD and anti-diabetic
treatment.
Subjects with diabetic mother vs. subjects with relatives 
others than mother with diabetes
The comparison between diabetic subjects with mother
with diabetes and diabetic subjects with relatives others
than mother with diabetes showed the following differ-
ences: diabetic subjects with mother with diabetes were
significantly younger (P = 0.003), had lower age at diabe-
tes diagnosis (P < 0.001), and a lower prevalence of hyper-
tension (P = 0.001) (Table 2).
No significant differences were observed regarding gender
distribution, blood pressure, HbA1c, BMI, plasma total
cholesterol levels, HDL-cholesterol levels, LDL-choles-
terol levels, triglycerides levels, dyslipidemia, retinopathy,
nephropathy, CAD and anti-diabetic treatment.
Subjects with parents with diabetes vs. subjects with no 
relatives with diabetes
When we compared diabetic subjects with diabetes in the
mother or/and father with diabetic subjects with no rela-
tives with diabetes we found that the following variables
were significantly different: age, age at diabetes diagnosis,
BMI, prevalence of dyslipidemia and retinopathy. The
group with parental diabetes was significantly younger (P
< 0.001), had lower age at diabetes diagnosis (P < 0.001),
higher BMI (P = 0.08) and higher prevalence of dyslipi-
demia (P = 0.06) as well as prevalence of retinopathy (P =
0.08) than the group with no diabetic relatives (Table 3).
There were no significant differences regarding gender dis-
tribution, blood pressure, HbA1c, plasma total cholesterol
levels, HDL-cholesterol levels, LDL-cholesterol levels, trig-
lycerides levels, prevalence of hypertension, nephropathy,
CAD and anti-diabetic treatment.
Discussion
In the present study the prevalence of diabetes in mothers
was threefold higher than in fathers of T2D patients. The
excess maternal transmission of T2D reported in the
present study is in line with studies from different popu-
lations [3,8,9,15-18]. Similar inheritance pattern has been
observed in North America [3], England [8], France [15],
Italy [16], Brazil [17], and China [9]. Also, an excess
maternal transmission has been observed in Pima Indi-
ans, which are characterized by the highest prevalence of
Table 1: Clinical and laboratory characteristics of the patients with diabetes in the mother or the father.
Mother Father P
n4 0 8 1 6 2
Age (years) 65.55 ± 10.55 64.09 ± 12.31 0.15
Males/females n (%) 192 (47.1)/216 (52.9) 90 (55.6)/72 (44.4) 0.07
Body mass index (Kg/m2) 30.99 ± 5.64 31.70 ± 6.22 0.19
Age at diabetes diagnosis (years) 50.86 ± 12.7 50.61 ± 13.18 0.83
Systolic blood pressure (mmHg) 1135.09 ± 18.81 135.71 ± 18.44 0.72
Diastolic blood pressure (mmHg) 79.23 ± 10.17 79.12 ± 11.93 0.91
HbA1c (%) 7.69 ± 3.83 7.80 ± 1.92 0.72
Total cholesterol (mg/dl) 207.06 ± 53.79 202.69 ± 88.33 0.48
HDL cholesterol (mg/dl) 46.95 ± 14.06 48.81 ± 19.77 0.23
LDL cholesterol (mg/dl) 127.13 ± 46.53 115.12 ± 39.76 0.006
Triglycerides (mg/dl) 165.65 ± 120.96 167.91 ± 105.79 0.84
Hypertension (yes) n (%) 233 (57.1) 105 (64.8) 0.05
Dyslipidemia (yes) n (%) 198 (48.5) 84 (51.9) 0.47
Retinopathy (yes) n (%) 80 (19.6) 24 (14.9) 0.19
Nephropathy (yes) n (%) 17 (4.2) 3 (1.9) 0.18
Coronary artery disease (yes) n (%) 67 (16.5) 24 (14.8) 0.62
Treatment for diabetes n (%)
Antidiabetic tablets 277 (67.9) 109 (67.3) 0.89
Insulin 125 (30.6) 50 (30.9) 0.96BMC Endocrine Disorders 2009, 9:12 http://www.biomedcentral.com/1472-6823/9/12
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Table 2: Clinical and laboratory characteristics of the patients with diabetes in the mother and relatives others than mother with 
diabetes.
Mother Relatives others than mother with diabetes P
n4 6 8 3 2 0
Age (years) 65.10 ± 10.63 67.47 ± 11.85 0.003
Males/females n (%) 247 (47.1)/221 (52.9) 155 (51.6)/165 (48.4) 0.22
Body mass index (Kg/m2) 31.03 ± 5.75 30.76 ± 5.89 0.52
Age at diabetes diagnosis (years) 50.58 ± 12.01 54.15 ± 13.01 <0.001
Systolic blood pressure (mmHg) 1135.25 ± 18.98 137.77 ± 21.41 0.08
Diastolic blood pressure (mmHg) 79.14 ± 10.18 79.72 ± 12.56 0.47
HbA1c (%) 7.69 ± 3.64 7.67 ± 1.76 0.91
Total cholesterol (mg/dl) 206.10 ± 52.74 204.88 ± 72.05 0.79
HDL cholesterol (mg/dl) 48.17 ± 23.78 48.98 ± 16.90 0.62
LDL cholesterol (mg/dl) 125.76 ± 45.40 121.65 ± 42.56 0.23
Triglycerides (mg/dl) 167.97 ± 120.57 159.88 ± 96.09 0.33
Hypertension (yes) n (%) 266 (56.7) 213 (66.6) 0.001
Dyslipidemia (yes) n (%) 230 (49.0) 155 (48.4) 0.86
Retinopathy (yes) n (%) 89 (19.0) 52 (16.3) 0.33
Nephropathy (yes) n (%) 19 (4.1) 8 (2.5) 0.24
Coronary artery disease (yes) n (%) 75 (16.1) 49 (15.3) 0.77
Treatment for diabetes n (%)
Antidiabetic tablets 314 (67.0) 214 (66.9) 0.98
Insulin 146 (31.1) 107 (33.4) 0.49
Table 3: Clinical and laboratory characteristics of patients with parents with diabetes (mother or father) and no relatives with 
diabetes.
Parents with diabetes No relatives with diabetes P
n 630 684
Age (years) 64.87 ± 11.07 68.09 ± 12.35 <0.001
Males/females n (%) 311 (49.4)/319 (50.6) 322 (47.1)/362 (52.9) 0.41
Body mass index (Kg/m2) 31.22 ± 5.87 30.67 ± 5.35 0.08
Age at diabetes diagnosis (years) 50.06 ± 12.32 54.21 ± 13.74 <0.001
Systolic blood pressure (mmHg) 1135.39 ± 18.83 136.31 ± 18.35 0.37
Diastolic blood pressure (mmHg) 79.14 ± 10.65 78.86 ± 10.27 0.64
HbA1c (%) 7.72 ± 3.28 7.68 ± 3.29 0.81
Total cholesterol (mg/dl) 205.19 ± 64.09 203.51 ± 44.65 0.59
HDL cholesterol (mg/dl) 48.29 ± 22.75 57.50 ± 13.73 0.46
LDL cholesterol (mg/dl) 122.95 ± 44.23 125.08 ± 40.99 0.39
Triglycerides (mg/dl) 168.08 ± 116.79 158.91 ± 89.59 0.12
Hypertension (yes) n (%) 371 (58.9) 425 (62.1) 0.12
Dyslipidemia (yes) n (%) 314 (49.8) 305 (44.6) 0.06
Retinopathy (yes) n (%) 113 (17.9) 99 (14.5) 0.08
Nephropathy (yes) n (%) 22 (3.51) 27 (3,9) 0.66
Coronary artery disease (yes) n (%) 99 (15.8) 115 (16.8) 0.59
Treatment for diabetes n (%)
Antidiabetic tablets 423 (67.1) 448 (65.5) 0.53
Insulin 195 (31.0) 215 (31.4) 0.84BMC Endocrine Disorders 2009, 9:12 http://www.biomedcentral.com/1472-6823/9/12
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diabetes [18]. However, studies in two different popula-
tions with high prevalence of diabetes have reported no
difference in parental transmission of T2D [12,19].
Finally, in the Framingham population, maternal and
paternal diabetes conferred equal risk for overt T2D
among offspring [20].
Several potential genetic and environmental factors have
been proposed to explain the excess maternal transmis-
sion of T2D. It is known that the intrauterine environ-
ment in mothers with diabetes during pregnancy is
associated with insulin resistance and adult T2D [12,21].
Furthermore, genetic factors, including mitochondrial
inheritance [22,10], genetic imprinting [23], and behav-
ioural risk factors passed on preferentially by the mother
[24,25]. Indeed, mutations on mitochondrial genes have
been described in families with diabetes and deafness [26]
and in subjects with T2D [27]. Finally, a study in over-
weight Latino youth showed a decline in insulin sensitiv-
ity and β-cell function that was influenced by a family
history of T2D on the maternal side [28].
Further analysis of the data revealed a different influence
of maternal and paternal diabetes on plasma LDL-choles-
terol levels and history of hypertension. Subjects with a
diabetic father had lower levels of plasma LDL-cholesterol
and had higher prevalence of hypertension than subjects
with a diabetic mother. The above findings are in accord-
ance with previous findings showing an association
between parental histories of hypertension and diabetes
and the clustering of these disorders in offspring [17,29].
However, a study in Pima Indians showed that maternal
but not paternal T2D mellitus was significantly associated
with higher blood pressure in children [6]. Regarding the
lipid profile, previous studies have showed a positive rela-
tionship between plasma LDL-cholesterol levels and
paternal history of diabetes [16] and higher serum triglyc-
eride levels in male offspring of T2D mothers than
females of the same group [7]. Also, a study showed that
diabetes in pregnant women causes a tendency to LDL
hypercholesterolemia in the offspring [30].
The comparison between patients with a diabetic parent
with patients without diabetic relatives revealed differ-
ences in age, age at diabetes diagnosis and BMI. Patients
with a diabetic parent were both younger and younger at
the age of diabetes diagnosis than patients without dia-
betic relatives. The above finding has been confirmed by
previous reports [5,15,16], suggesting that the age at dia-
betes onset might be genetically determined. Another sim-
ple explanation is that a familial history of diabetes might
lead to more frequent contacts with medical practitioners.
In contrast with a previous study [16], no age difference at
the time of diabetes diagnosis was observed in diabetic
subjects regarding the maternal or paternal history of dia-
betes.
Patients with familial diabetes displayed significantly
higher BMI values than those without familial diabetes,
confirming previous results [31]. The above result empha-
sizes the importance of the combination of genetic and
environmental factors for the clinical onset of diabetes.
The observation that the BMI of offspring of gestational
diabetic mothers was significantly higher than that of off-
spring of mothers with impaired glucose tolerance shows
the significant influence by the maternal uterine environ-
ment [32].
Patients with a diabetic parent had higher prevalence of
dyslipidemia and retinopathy compared with patients
with no diabetic relatives. It seems that the observed early
manifestation of diabetes in subjects with diabetic parent
has as a result the longer exposure of the subjects to the
detrimental effects of diabetes per se, resulting to the ear-
lier development of diabetic complications. However, a
study in type 1 diabetic patients showed that proliferative
retinopathy was not associated with parental hyperten-
sion or diabetes [33]. No difference in the degree of met-
abolic control and the prevalence of the rest chronic
complications were observed between the two groups.
Limitations
Our study has some limitations. As data were collected
from a referral tertiary center of diabetes, they cannot be
extrapolated to the total population. In addition, only
type 2 diabetic patients with at least three visits during the
last year were enrolled into the study. The collected data
were self-reported and, therefore, do not allow confirma-
tion of diabetes in the parents. However, a complete
agreement between reported family history by the patients
and family members on diabetic occurrence has been val-
idated [34,35]. Other potential reporting biases that also
could explain the excess maternal transmission of T2D
include the longer average life span in women that could
increase the likelihood that mothers develop T2D [15],
and that men with insulin resistance-associated cardiovas-
cular disease could die before the clinic diagnostic of dia-
betes [36]. Also, this underestimation is most likely on the
paternal side, as women are more likely to seek medical
care and have their diabetes diagnosed. However, no sig-
nificant gender differences were observed in the present
study.
Conclusion
In conclusion, the present study showed an excess mater-
nal transmission of T2D in a sample of Greek diabetic
patients. However, no different influence was found
between maternal and paternal diabetes on the clinical
characteristics of diabetic patients except for plasma LDL-BMC Endocrine Disorders 2009, 9:12 http://www.biomedcentral.com/1472-6823/9/12
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cholesterol levels and presence of hypertension. In addi-
tion, the presence of a family history of diabetes resulted
to an early onset of the disease to the offspring. With the
current epidemic of obesity and T2D in the young, family
history information may serve as a useful tool for public
health. Therefore, interventions to change health behav-
iors among families might reduce the risk of diabetes in
the offspring of diabetic parents.
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